期刊文献+

角膜缘损伤模型静脉移植兔骨髓间充质干细胞体内动态分布特点的初步研究 被引量:4

Research on dynamic distribution of the bone marrow mesenchymal stem cells after intravenous transplantation in the corneal injury model
下载PDF
导出
摘要 目的骨髓间充质干细胞(bone marrow mesenchymal stem cells,MMSCs)取材方便,可使器官、组织的修复和重建成为可能,但MMSCs在体内的分布、归巢等问题一直是研究热点和难点。文中探讨角膜缘损伤模型静脉移植兔MMSCs的体内动态分布特点。方法选用2.5 kg,月龄2个月的新西兰大白兔60只,入笼养至7 d。随机分为2组,每组30只,正常兔作为对照组,角膜缘碱烧伤兔(制备右眼)作为实验组。分别进行静脉移植MMSCs,观察动物进食、休息状态、行为、排便,是否有腹泻、毛色变化、脱毛等;观察眼部是否有睑球粘连、感染。分别于细胞移植后第3、21、60天耳缘静脉抽取2ml外周血后,空气栓塞处死兔(每组每次处死6只),将眼、肺、心、肝、脾、肾、肌肉和脑组织作冰冻切片,片厚4μm。结果对照组移植术后不同天数MMSCs细胞数目比较的差异无统计学意义(P>0.05);实验组移植术后第3天,外周血中的MMSCs数量较高(2.98±0.11)个,与第21、60天比较,差异有统计学意义(P<0.05),且移植MMSCs的起始数量与外周血中第3天的流式细胞学检测结果呈正相关(r=0.567,P<0.05)。2组间移植术后第3、21、60天细胞数目比较的差异均有统计学意义(P<0.05)。激光共聚焦显像镜下可观察到外源性MMSCs迁移至角膜。对照组在角膜、虹膜、视网膜、脉络膜、虹膜可偶见MMSCs分布。实验组MMSCs数量由多至少依次为角膜缘、角膜中央、结膜、视网膜、脉络膜、虹膜;且MMSCs在角膜缘的分布有"聚集现象";MMSCs经静脉移植后,心、肝、脾肺、肾、肌肉、脑均可见到分布。移植术后不同时间,肺MMSCs数量变化差异有统计学意义(P<0.05),而脾组织中MMSCs数量变化差异无统计学意义(P>0.05)。结论在角膜损伤修复过程中,静脉移植MMSCs可归巢至角膜损伤部位,在全身实质器官中均有分布,肺组织是主要截流场所,脾是MMSCs破坏与溶解场所。 Objective It is easy to obtain bone marrow mesenchymal stem ceils (MMSCs), which makes repair and recon- struction of tissue and organs possible, but their distribution and homing in vivo are research difficulty and hot spot. The objective of this study was to to investigate the dynamic in vivo distribution characteristics of MMSCs after intravenous transplantation into the rabbitmodel of corneal injury. Methods Sixty two-month-old New Zealand rabbits with body weight of 2.5 kg each were selected and fed in a cage for 7 days. They were randomly divided into two groups with 30 rabbits in each group. Normal rabbits were used as normal control group, and rabbits suffering from limbal alkali bum (preparation ofthe right eye) as experimental group. MMSCs were implanted intravenously and rabbits' feeding, resting state, incontinent, any diar- rhea, hair color, hair removal and other changes were observed. All of them were observed whether symblepharon or infection in the eyes or not. After transplantation for 3, 21,60 days, 2 ml of peripheral blood was extracted through ear vein. Rabbits were sacrificed through air embolism ( n = 6 for each time point in each group), frozen sections with thick slices of 4 μm of the eye, heart, lung, liver, spleen, kidney and muscle, brain were made. Results In the normal control group, there was no difference for the number of MMSCs among different time points after transplantation ( P 〉 0.05 ). Numbers of MMSCs of peripheral blood (2.98 + 0. 11 ) were higher after transplantation for 3 days that those after transplantation for 21, 60 days (P 〈 0.05), and initial numbers of transplanted MMSCs positively correlated with flow cytometry assay results of peripheral blood 3 days after transplantation ( r = 0. 567, P 〈 0.05 ). There was difference for numbers of MMSCs for both groups 3, 21, 60 days after transplantation (P 〈 0.05). The exogenous MMSCs migrating to cornea were observed under confocal laser microscopy. The labeled MMSCs can be occasionally observed in the corneal limbus, cornea central, conjunctiva, retina, choroid, iris in the normal groups, while the labeled MMSCs were from more to less in order in the corneal limbus, central cornea, conjunctiva, retina, choroid, and iris, and MMSCs tended to gather in the corneal limbus. MMSCs can be observed in the heart, liver, spleen, lungs, muscle, and brain after intravenous injection. There was statistical differ- ence for the numbers of MMSCs in the lungs at the different time points after transplantation ( P 〈 0.05 ), while there was no difference for the numbers of MMSCs in the spleen ( P 〉 0.05 ). Conclusion Intravenously injected MMSCs can home to injury location of cornea during healing of cornea injury. These MMSCs can distributed in all parenchymal organs, lung is the main closure organ, and spleen is the organ of destruction and dissolution.
出处 《医学研究生学报》 CAS 北大核心 2013年第2期128-133,共6页 Journal of Medical Postgraduates
基金 武警医学院博士启动基金(WYB201005)
关键词 骨髓间充质干细胞 移植 角膜缘损伤模型 动态分布 Bone marrow mesenchymal stem cells Transplantation Corneal injury model Dynamic distribution
  • 相关文献

参考文献22

  • 1Pittenger MF, Mackay AM, Beck SC, et al. Muhilineage poten- tial of adult human mesenchymal stem cells[ Jl. Science, 1999, 284 ( 5411 ) : 143-147.
  • 2Prockop DJ. Marrow stromal cells as stem cells for nonhematopoi- etic tissues[ Jl. Science, 1997, 276(5309) :71-74.
  • 3Rzhaninova AA, Gomostaeva SN, Goldshtein DV. Isolation and phe- notypical characterization of mesenchymal stem cells from human fe- tal thymus [ J ]. Bull ExpBiol Med, 2005, 139 ( 11 ) : 134-401.
  • 4吴家昌,杨彤涛,许啸,文艳华,韩建伟,范清宇,马保安.人骨髓间充质干细胞体外向软骨细胞分化的实验研究[J].医学研究生学报,2010,23(2):128-132. 被引量:10
  • 5Prockop DJ. Marrow stromal cells as stem cells for nonhematopoi- etic tissues [ J ]. Science, 1997,276 ( 5309 ) :71-74.
  • 6李玲,王斌,白志强,李鹏,王海涛,刘海燕,姜光域,宋旭霞,钱冬萌,闫志勇,丁守怡.人巨细胞病毒诱导分化中的神经干细胞分泌神经生长因子前体[J].医学研究生学报,2010,23(9):904-909. 被引量:4
  • 7Kanski JJ. Clinical Ophthamology[ M ]. New Deihi: Oversea Publishing House, 2001 : 609-612.
  • 8Ball LM, Bernardo ME, Roelofs H. Cotransplantation of ex vivo expanded mesenchymal stem ceils accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidenticai hemato- poietic stem-cell transplantation [ J ]. Blood, 2007, 110 (7) : 2764-2767.
  • 9Yang JW, de Isla N, Huselstein C, et al. Evaluation of human MMSCs cell cycle, viability and differentiation in micromass cul- ture [ J ]. Biorheology, 2006, 43 ( 3 ) :489-496.
  • 10Peled A, Kollet O, Ponomaryov T, et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on im-mature human CD34 + cells:role in transendothelial/stromal migration and engraftment of NOD/SCID mice [ J ]. Blood, 2000,95 (6) : 3289-3296.

二级参考文献12

共引文献12

同被引文献26

  • 1侯锐,毛天球,陈书军,高瞻,陶凯,陈富林.rhBMP-2及rhbFGF对兔骨髓间充质干细胞分化作用长期效应的实验研究[J].医学研究生学报,2004,17(8):694-697. 被引量:4
  • 2王共先,汪泱,刘伟鹏,张中华,黄学明,谢安.骨髓间充质干细胞—聚乳酸聚乙醇酸共聚复合物支架修复组织损伤的实验研究[J].中华医学杂志,2006,86(6):403-406. 被引量:6
  • 3王晶,张洹,刘华.骨髓间充质细胞与速固化磷酸钙支架共培养的实验研究[J].中国矫形外科杂志,2007,15(9):706-708. 被引量:3
  • 4Rey-Rico A, Silva M, Couceiro J, et al. Osteogenic effi- ciency of in situ gelling poloxamine systems with and without bone morphogenetic protein-2[J]. Eur Cell Ma- ter,2011,21;317-340.
  • 5Schmidmaier G,Schwabe P, Strobel C, et al. Carrier sys- tems and application of growth factors in orthopaedics [J]. Injury,2008,39(Suppl 2) :S37-43.
  • 6Fournier E. Passirani C. Montero-Menei CN, et al. Bio- compatibility of implantable synthetic polymeric drug car- tiers: focus on brain biocompatibility[J]. Biomaterials, 2003,24(19) :3311-3331.
  • 7Chen L,Liu L,Li C,et al. A new growth factor controlled drug release system to promote healing of bone fractures: nanospheres of recombinant human bone morphogenetic-2 and polylactic acid[J]. J Nanosci Nanotechnol. 2011,11 (4) : 3107-3114.
  • 8Wen J, Kim G J, Leong KW. Poly ( D, L-lactide-co-ethyl ethylene phosphate)s as new drug carriers[J]. J Control Release, 2003,92 ( ]/2 ) : 39-48.
  • 9Yoshikawa T,Ohgushi H,Nakajima H,et al. In vivo os- teogenic durability of cultured bone in porous ceramics:anovel method for autogenous bone graft substitution[J].Transplantation, 2000,69 ( 1 ) : 128-134.
  • 10Qi R, Shen M, Cao X, et al. Exploring the dark side of MTT viability assay of cells cultured onto electrospun PLGA-based composite nanofibrous scaffolding materials [J]. Analyst, 2011,136 (14) : 2897-2903.

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部